{"transactions":[{"id":1489373,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:12:25.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":false,"shares":2060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":15417,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":2060},"source":{"system":"sec-edgar","filing":"0000950170-24-069424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024069424/ownership.xml","form_type":"4"}},{"id":1489372,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T21:12:25.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":2060,"price":135.93,"value":280015.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":21299,"source":{"system":"sec-edgar","filing":"0000950170-24-069424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024069424/ownership.xml","form_type":"4"}},{"id":1489371,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T21:12:25.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":true,"shares":2060,"price":38.46,"value":79227.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":23359,"source":{"system":"sec-edgar","filing":"0000950170-24-069424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024069424/ownership.xml","form_type":"4"}},{"id":1496269,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027."}],"balance_after":15022,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496268,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 23, 2028."}],"balance_after":17690,"derivative":{"exercise_price":83.14,"expiration_date":"2034-02-23","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496267,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":23167,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496266,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":17477,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496265,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":84,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496264,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"sale","planned":false,"acquired":false,"shares":8655,"price":141.8,"value":1227279.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $141.45 to $142.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21299,"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496263,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"sale","planned":false,"acquired":false,"shares":9345,"price":141.06,"value":1318205.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $140.445 to $141.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":29954,"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496262,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":66.1,"value":330500.0,"ownership":{"direct":true},"balance_after":39299,"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496261,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":83.14,"value":83140.0,"ownership":{"direct":true},"balance_after":34299,"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496260,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":13.28,"value":66400.0,"ownership":{"direct":true},"balance_after":33299,"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496259,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":38.46,"value":192300.0,"ownership":{"direct":true},"balance_after":28299,"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496258,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2000,"price":16.14,"value":32280.0,"ownership":{"direct":true},"balance_after":23299,"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1496257,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:30:11.000Z","date":"2024-05-29","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":141.27,"value":282540.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $140.75 to $141.4025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21299,"source":{"system":"sec-edgar","filing":"0000950170-24-067358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024067358/ownership.xml","form_type":"4"}},{"id":1522947,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-08T20:33:07.000Z","date":"2024-05-06","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":22477,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-055800","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024055800/ownership.xml","form_type":"4"}},{"id":1522946,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-08T20:33:07.000Z","date":"2024-05-06","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":128,"value":1920000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":23299,"source":{"system":"sec-edgar","filing":"0000950170-24-055800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024055800/ownership.xml","form_type":"4"}},{"id":1522945,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-08T20:33:07.000Z","date":"2024-05-06","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":38.46,"value":576900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":38299,"source":{"system":"sec-edgar","filing":"0000950170-24-055800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024055800/ownership.xml","form_type":"4"}},{"id":1552560,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-02T21:28:45.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":37477,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-040393","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024040393/ownership.xml","form_type":"4"}},{"id":1552559,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-02T21:28:45.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":74.01,"value":1110150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":23299,"source":{"system":"sec-edgar","filing":"0000950170-24-040393","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024040393/ownership.xml","form_type":"4"}},{"id":1552558,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-02T21:28:45.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":38.46,"value":576900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":38299,"source":{"system":"sec-edgar","filing":"0000950170-24-040393","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024040393/ownership.xml","form_type":"4"}},{"id":1580018,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-12T23:28:34.000Z","date":"2024-03-08","kind":"sale","planned":false,"acquired":false,"shares":1903,"price":87.63,"value":166759.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction pursuant to the terms of the RSU award."}],"balance_after":23299,"source":{"system":"sec-edgar","filing":"0000950170-24-030275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024030275/ownership.xml","form_type":"4"}},{"id":1593651,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T23:20:25.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":52477,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-026478","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024026478/ownership.xml","form_type":"4"}},{"id":1593650,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-05T23:20:25.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":82.8,"value":1242000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":25202,"source":{"system":"sec-edgar","filing":"0000950170-24-026478","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024026478/ownership.xml","form_type":"4"}},{"id":1593649,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-05T23:20:25.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":38.46,"value":576900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":40202,"source":{"system":"sec-edgar","filing":"0000950170-24-026478","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024026478/ownership.xml","form_type":"4"}},{"id":1614429,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-27T22:00:34.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":18690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 23, 2024 until the option is fully vested on February 23, 2028, subject to continued service."}],"balance_after":18690,"derivative":{"exercise_price":83.14,"expiration_date":"2034-02-23","underlying":"Common Stock","underlying_shares":18690},"source":{"system":"sec-edgar","filing":"0000950170-24-021334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024021334/ownership.xml","form_type":"4"}},{"id":1614428,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-27T22:00:34.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":12127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 12,127 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":25202,"source":{"system":"sec-edgar","filing":"0000950170-24-021334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024021334/ownership.xml","form_type":"4"}},{"id":1660590,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T23:56:07.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":false,"shares":2523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025."}],"balance_after":67477,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":2523},"source":{"system":"sec-edgar","filing":"0000950170-24-010796","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024010796/ownership.xml","form_type":"4"}},{"id":1660589,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T23:56:07.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":false,"shares":3644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024."}],"balance_after":2084,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":3644},"source":{"system":"sec-edgar","filing":"0000950170-24-010796","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024010796/ownership.xml","form_type":"4"}},{"id":1660588,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T23:56:07.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":false,"shares":8833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":28167,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":8833},"source":{"system":"sec-edgar","filing":"0000950170-24-010796","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024010796/ownership.xml","form_type":"4"}},{"id":1660587,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-02T23:56:07.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":85.45,"value":1281750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,075 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":13075,"source":{"system":"sec-edgar","filing":"0000950170-24-010796","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024010796/ownership.xml","form_type":"4"}},{"id":1660586,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-02T23:56:07.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":true,"shares":2523,"price":38.46,"value":97034.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":28075,"source":{"system":"sec-edgar","filing":"0000950170-24-010796","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024010796/ownership.xml","form_type":"4"}},{"id":1660585,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-02T23:56:07.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":true,"shares":3644,"price":16.14,"value":58814.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":25552,"source":{"system":"sec-edgar","filing":"0000950170-24-010796","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024010796/ownership.xml","form_type":"4"}},{"id":1660584,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-02T23:56:07.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":true,"shares":8833,"price":13.28,"value":117302.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023."}],"balance_after":21908,"source":{"system":"sec-edgar","filing":"0000950170-24-010796","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024010796/ownership.xml","form_type":"4"}},{"id":1690611,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T22:00:21.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":37000,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-001054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024001054/ownership.xml","form_type":"4"}},{"id":1690610,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:00:21.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":77.07,"value":1156050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,075 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":13075,"source":{"system":"sec-edgar","filing":"0000950170-24-001054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024001054/ownership.xml","form_type":"4"}},{"id":1690609,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:00:21.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":13.28,"value":199200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022."}],"balance_after":28075,"source":{"system":"sec-edgar","filing":"0000950170-24-001054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024001054/ownership.xml","form_type":"4"}},{"id":1732171,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T21:30:26.000Z","date":"2023-11-17","kind":"gift","planned":false,"acquired":false,"shares":5714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 13,075 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":13075,"source":{"system":"sec-edgar","filing":"0000950170-23-065520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023065520/ownership.xml","form_type":"4"}},{"id":1764858,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T21:00:06.000Z","date":"2023-10-02","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024."}],"balance_after":5728,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-23-051960","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023051960/ownership.xml","form_type":"4"}},{"id":1764857,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-04T21:00:06.000Z","date":"2023-10-02","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":54.22,"value":271100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,075 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":18789,"source":{"system":"sec-edgar","filing":"0000950170-23-051960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023051960/ownership.xml","form_type":"4"}},{"id":1764856,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-04T21:00:06.000Z","date":"2023-10-02","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":16.14,"value":80700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022."}],"balance_after":23789,"source":{"system":"sec-edgar","filing":"0000950170-23-051960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017023051960/ownership.xml","form_type":"4"}},{"id":1907819,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-02T22:31:56.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024."}],"balance_after":10728,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-23-012010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323012010/doc4.xml","form_type":"4"}},{"id":1907818,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-02T22:31:56.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":79.05,"value":395250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,075 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":18789,"source":{"system":"sec-edgar","filing":"0000899243-23-012010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323012010/doc4.xml","form_type":"4"}},{"id":1907817,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-02T22:31:56.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":16.14,"value":80700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022."}],"balance_after":23789,"source":{"system":"sec-edgar","filing":"0000899243-23-012010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323012010/doc4.xml","form_type":"4"}},{"id":1978436,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T22:00:42.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024."}],"balance_after":15728,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-23-006758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323006758/doc4.xml","form_type":"4"}},{"id":1978435,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-02T22:00:42.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":5000,"price":79.51,"value":397550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,075 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":18789,"source":{"system":"sec-edgar","filing":"0000899243-23-006758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323006758/doc4.xml","form_type":"4"}},{"id":1978434,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-02T22:00:42.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":5000,"price":16.14,"value":80700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":23789,"source":{"system":"sec-edgar","filing":"0000899243-23-006758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323006758/doc4.xml","form_type":"4"}},{"id":1998432,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-23T01:00:19.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":20022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service."}],"balance_after":20022,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":20022},"source":{"system":"sec-edgar","filing":"0000899243-23-005894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323005894/doc4.xml","form_type":"4"}},{"id":1998431,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-23T01:00:19.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":13075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 13,075 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":18789,"source":{"system":"sec-edgar","filing":"0000899243-23-005894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323005894/doc4.xml","form_type":"4"}},{"id":2031950,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:06:24.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024."}],"balance_after":20728,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-23-003882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323003882/doc4.xml","form_type":"4"}},{"id":2031949,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-03T22:06:24.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":5000,"price":62.64,"value":313200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-23-003882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323003882/doc4.xml","form_type":"4"}},{"id":2031948,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-03T22:06:24.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":5000,"price":16.14,"value":80700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":10714,"source":{"system":"sec-edgar","filing":"0000899243-23-003882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323003882/doc4.xml","form_type":"4"}},{"id":2051978,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-18T23:02:15.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024."}],"balance_after":25728,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-23-002079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323002079/doc4.xml","form_type":"4"}},{"id":2051977,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-18T23:02:15.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":5000,"price":60.12,"value":300600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-23-002079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323002079/doc4.xml","form_type":"4"}},{"id":2051976,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-18T23:02:15.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":5000,"price":16.14,"value":80700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":10714,"source":{"system":"sec-edgar","filing":"0000899243-23-002079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323002079/doc4.xml","form_type":"4"}},{"id":2095473,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-05T22:30:27.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024."}],"balance_after":30728,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-037662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322037662/doc4.xml","form_type":"4"}},{"id":2095472,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-05T22:30:27.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":31,"price":62.15,"value":1926.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.10 to $62.15, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-22-037662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322037662/doc4.xml","form_type":"4"}},{"id":2095471,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-05T22:30:27.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":9969,"price":61.3,"value":611099.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.05 to $62.04, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5745,"source":{"system":"sec-edgar","filing":"0000899243-22-037662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322037662/doc4.xml","form_type":"4"}},{"id":2095470,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-05T22:30:27.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":10000,"price":16.14,"value":161400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15714,"source":{"system":"sec-edgar","filing":"0000899243-22-037662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322037662/doc4.xml","form_type":"4"}},{"id":2120818,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-09T22:00:32.000Z","date":"2022-11-07","kind":"exercise","acquired":false,"shares":9272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024."}],"balance_after":40728,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":9272},"source":{"system":"sec-edgar","filing":"0000899243-22-035449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322035449/doc4.xml","form_type":"4"}},{"id":2120817,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-09T22:00:32.000Z","date":"2022-11-07","kind":"exercise","acquired":false,"shares":728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.21,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":728},"source":{"system":"sec-edgar","filing":"0000899243-22-035449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322035449/doc4.xml","form_type":"4"}},{"id":2120816,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-09T22:00:32.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":10000,"price":56.72,"value":567200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $56.66 to $57.48, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-22-035449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322035449/doc4.xml","form_type":"4"}},{"id":2120815,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-09T22:00:32.000Z","date":"2022-11-07","kind":"exercise","acquired":true,"shares":9272,"price":16.14,"value":149650.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15714,"source":{"system":"sec-edgar","filing":"0000899243-22-035449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322035449/doc4.xml","form_type":"4"}},{"id":2120814,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-09T22:00:32.000Z","date":"2022-11-07","kind":"exercise","acquired":true,"shares":728,"price":2.21,"value":1608.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":6442,"source":{"system":"sec-edgar","filing":"0000899243-22-035449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322035449/doc4.xml","form_type":"4"}},{"id":2143554,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:33:29.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":728,"derivative":{"exercise_price":2.21,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-032662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322032662/doc4.xml","form_type":"4"}},{"id":2143553,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-04T20:33:29.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":10000,"price":41.74,"value":417400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-22-032662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322032662/doc4.xml","form_type":"4"}},{"id":2143552,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-04T20:33:29.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":10000,"price":2.21,"value":22100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15714,"source":{"system":"sec-edgar","filing":"0000899243-22-032662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322032662/doc4.xml","form_type":"4"}},{"id":2167066,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-02T21:00:18.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":10728,"derivative":{"exercise_price":2.21,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-030303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322030303/doc4.xml","form_type":"4"}},{"id":2167065,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-02T21:00:18.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":10000,"price":50.93,"value":509300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.90 to $50.97, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-22-030303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322030303/doc4.xml","form_type":"4"}},{"id":2167064,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-02T21:00:18.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":10000,"price":2.21,"value":22100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15714,"source":{"system":"sec-edgar","filing":"0000899243-22-030303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322030303/doc4.xml","form_type":"4"}},{"id":2190396,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-09T22:00:16.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":20728,"derivative":{"exercise_price":2.21,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-028140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322028140/doc4.xml","form_type":"4"}},{"id":2190395,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T22:00:16.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":10000,"price":48.09,"value":480900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $48.01 to $48.79, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-22-028140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322028140/doc4.xml","form_type":"4"}},{"id":2190394,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T22:00:16.000Z","date":"2022-08-08","kind":"exercise","acquired":true,"shares":10000,"price":2.21,"value":22100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15714,"source":{"system":"sec-edgar","filing":"0000899243-22-028140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322028140/doc4.xml","form_type":"4"}},{"id":2211223,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-06T22:19:20.000Z","date":"2022-07-05","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":30728,"derivative":{"exercise_price":2.21,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-025484","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322025484/doc4.xml","form_type":"4"}},{"id":2211222,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-06T22:19:20.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":10000,"price":35,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-22-025484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322025484/doc4.xml","form_type":"4"}},{"id":2211221,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-06T22:19:20.000Z","date":"2022-07-05","kind":"exercise","acquired":true,"shares":10000,"price":2.21,"value":22100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15714,"source":{"system":"sec-edgar","filing":"0000899243-22-025484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322025484/doc4.xml","form_type":"4"}},{"id":2373902,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-24T22:45:29.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":52000,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0000899243-22-007674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322007674/doc4.xml","form_type":"4"}},{"id":2574308,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-09T22:14:32.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-035480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321035480/doc4.xml","form_type":"4"}},{"id":2574307,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-09T22:14:32.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":10000,"price":35,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-21-035480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321035480/doc4.xml","form_type":"4"}},{"id":2574306,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-09T22:14:32.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":10000,"price":0.67,"value":6700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15714,"source":{"system":"sec-edgar","filing":"0000899243-21-035480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321035480/doc4.xml","form_type":"4"}},{"id":2631554,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-16T21:02:20.000Z","date":"2021-07-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":10000,"derivative":{"exercise_price":0.67,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-028668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321028668/doc4.xml","form_type":"4"}},{"id":2631553,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-16T21:02:20.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":10000,"price":35,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-21-028668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321028668/doc4.xml","form_type":"4"}},{"id":2631552,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-16T21:02:20.000Z","date":"2021-07-15","kind":"exercise","acquired":true,"shares":10000,"price":0.67,"value":6700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15714,"source":{"system":"sec-edgar","filing":"0000899243-21-028668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321028668/doc4.xml","form_type":"4"}},{"id":2659862,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T21:08:32.000Z","date":"2021-06-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":20000,"derivative":{"exercise_price":0.665,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-025021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321025021/doc4.xml","form_type":"4"}},{"id":2659861,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-21T21:08:32.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":10000,"price":30,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-21-025021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321025021/doc4.xml","form_type":"4"}},{"id":2659860,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-21T21:08:32.000Z","date":"2021-06-17","kind":"exercise","acquired":true,"shares":10000,"price":0.665,"value":6650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-025021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321025021/doc4.xml","form_type":"4"}},{"id":2682222,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T21:10:14.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":5714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":29999,"derivative":{"exercise_price":0.67,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":5714},"source":{"system":"sec-edgar","filing":"0000899243-21-021820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321021820/doc4.xml","form_type":"4"}},{"id":2682221,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-03T21:10:14.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":5714,"price":0.67,"value":3828.38,"ownership":{"direct":true},"balance_after":5714,"source":{"system":"sec-edgar","filing":"0000899243-21-021820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321021820/doc4.xml","form_type":"4"}},{"id":2785243,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-16T22:14:36.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":35713,"derivative":{"exercise_price":0.67,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-012009","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321012009/doc4.xml","form_type":"4"}},{"id":2785242,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-16T22:14:36.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":10000,"price":39.81,"value":398100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $39.59 to $40.58, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-012009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321012009/doc4.xml","form_type":"4"}},{"id":2785241,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-16T22:14:36.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":10000,"price":0.67,"value":6700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-012009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321012009/doc4.xml","form_type":"4"}},{"id":2828870,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-26T22:53:05.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":70000,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000899243-21-008458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321008458/doc4.xml","form_type":"4"}},{"id":2853150,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T22:43:55.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":45713,"derivative":{"exercise_price":0.67,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-006942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321006942/doc4.xml","form_type":"4"}},{"id":2853149,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:43:55.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":10000,"price":31.33,"value":313300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $31.00 to $31.82, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-006942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321006942/doc4.xml","form_type":"4"}},{"id":2853148,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:43:55.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":10000,"price":0.67,"value":6700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-006942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321006942/doc4.xml","form_type":"4"}},{"id":2868388,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-11T00:00:16.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":55713,"derivative":{"exercise_price":0.67,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0000899243-21-005748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321005748/doc4.xml","form_type":"4"}},{"id":2868387,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-11T00:00:16.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":1429,"price":25.01,"value":35739.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-005748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321005748/doc4.xml","form_type":"4"}},{"id":2868386,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-11T00:00:16.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":1429,"price":0.67,"value":957.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1429,"source":{"system":"sec-edgar","filing":"0000899243-21-005748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321005748/doc4.xml","form_type":"4"}},{"id":2868385,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":90236,"kind":"person","name":"Gordon Stephen","position":1,"cik":"0001774274","reported_name":"Gordon Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-11T00:00:16.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":8571,"price":25.01,"value":214360.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-005748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321005748/doc4.xml","form_type":"4"}}],"next_cursor":"2021-02-11T00:00:16.000000Z,2868385"}